Balyasny Asset Management LLC Personalis, Inc. Transaction History

Balyasny Asset Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.17 - $1.65 $77,097 - $108,726	65,895 New	65,895 $77,000
Q2 2023 Aug 14, 2023	SELL	$1.8 - $3.19 $1.62 Million - $2.86 Million	-897,252 Reduced 89.31%	107,358 $201,000
Q1 2023 May 15, 2023	BUY	$2.01 - $4.17 $2.02 Million - $4.19 Million	1,004,610 New	1,004,610 $2.77 Million

30.1M

27.5K

85.4K

Ticker PSNL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 45,918,400
Market Cap $265M
Description
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.